Literature DB >> 1906291

Cytogenetic and cellular characteristics of a human embryonal rhabdomyosarcoma cell line, RMS-YM.

K Kubo1, T Naoe, K R Utsumi, Y Ishiguro, K Ueda, H Shiku, K Yamada.   

Abstract

A human tumour cell line, designated RMS-YM, was established from a childhood rhabdomyosarcoma. The monolayer cells were polygonal, round or spindle-shaped. The cells became multilayered and formed many focal piles when confluent. RMS-YM became stable with a doubling time of about 30 h and has been maintained for 104 passages to date. Tumourigenicity of the cells was confirmed by heterotransplantation into nude mice. Morphological features were similar to those of the primary tumour, and myofibrils were found by electron microscopy. The expression of desmin and human myoglobin, and high levels of striated muscle system specific enzymes were recognised. Chromosomal analysis revealed possible gene amplification in the form of homogeneously staining regions. Oncogene analysis was performed on the primary tumour and the cell line, but neither N-myc nor N-ras genes were amplified, nor were Ki-ras, Ha-ras or N-ras genes mutated at the 12th, 13th and 61st codons. The RMS-YM cell line may provide a system to identify novel genes which are amplified in rhabdomyosarcoma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1906291      PMCID: PMC1972520          DOI: 10.1038/bjc.1991.193

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

Review 1.  The molecular genetics of cancer.

Authors:  J M Bishop
Journal:  Science       Date:  1987-01-16       Impact factor: 47.728

2.  Consistent chromosomal translocation in alveolar rhabdomyosarcoma.

Authors:  C Turc-Carel; S Lizard-Nacol; E Justrabo; M Favrot; T Philip; E Tabone
Journal:  Cancer Genet Cytogenet       Date:  1986-01-15

3.  Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers.

Authors:  Y Nagata; M Abe; K Kobayashi; K Yoshida; T Ishibashi; T Naoe; E Nakayama; H Shiku
Journal:  Cancer Res       Date:  1990-02-01       Impact factor: 12.701

4.  Nonrandom chromosome alterations in rhabdomyosarcoma.

Authors:  J Trent; J Casper; P Meltzer; F Thompson; J Fogh
Journal:  Cancer Genet Cytogenet       Date:  1985-04-01

5.  Distribution of immunoreactive carbonic anhydrase III in various human tissues determined by a sensitive enzyme immunoassay method.

Authors:  K Kato; K Mokuno
Journal:  Clin Chim Acta       Date:  1984-08-31       Impact factor: 3.786

6.  Characterization of a human rhabdomyosarcoma cell strain in tissue culture.

Authors:  M Sekiguchi; Y Shiroko; T Suzuki; M Imada; M Miyahara; G Fujii
Journal:  Biomed Pharmacother       Date:  1985       Impact factor: 6.529

7.  A specific chromosomal abnormality in rhabdomyosarcoma.

Authors:  E C Douglass; M Valentine; E Etcubanas; D Parham; B L Webber; P J Houghton; J A Houghton; A A Green
Journal:  Cytogenet Cell Genet       Date:  1987

8.  RMZ: a new cell line from a human alveolar rhabdomyosarcoma. In vitro expression of embryonic myosin.

Authors:  P Nanni; S Schiaffino; C De Giovanni; G Nicoletti; G Prodi; B Del Re; V Eusebi; C Ceccarelli; L Saggin; P L Lollini
Journal:  Br J Cancer       Date:  1986-12       Impact factor: 7.640

9.  Comparative studies between a new human rhabdomyosarcoma cell line, JR-1 and its tumour of origin.

Authors:  J Clayton; J R Pincott; J A van den Berghe; J T Kemshead
Journal:  Br J Cancer       Date:  1986-07       Impact factor: 7.640

10.  Diversity of cellular molecules in human cells detected by monoclonal antibodies reactive with c-myc proteins produced in Escherichia coli.

Authors:  T Naoe; N Nozaki; K Yamada; T Okazaki; E Nakayama; Y Kurosawa; H Shiku
Journal:  Jpn J Cancer Res       Date:  1989-08
View more
  5 in total

1.  Efficacy of a third-generation oncolytic herpes simplex virus in refractory soft tissue sarcoma xenograft models.

Authors:  Masahiko Hatta; Masaki Kaibori; Hideyuki Matsushima; Terufumi Yoshida; Tadayoshi Okumura; Mikio Hayashi; Kengo Yoshii; Tomoki Todo; Mitsugu Sekimoto
Journal:  Mol Ther Oncolytics       Date:  2022-04-26       Impact factor: 6.311

2.  In vitro differentiation and proliferation in a newly established human rhabdomyosarcoma cell line.

Authors:  A Ogose; T Motoyama; T Hotta; H Watanabe
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

3.  Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: utility and pitfalls.

Authors:  Ashley R P Hinson; Rosanne Jones; Lisa E S Crose; Brian C Belyea; Frederic G Barr; Corinne M Linardic
Journal:  Front Oncol       Date:  2013-07-17       Impact factor: 6.244

4.  Characterization of a new human embryonal rhabdomyosarcoma cell line, RMS-GR.

Authors:  J E Fernández; J Prados; C Melquizo; N Arena; F Malavasi; L Alvarez; A Aránega
Journal:  Jpn J Cancer Res       Date:  1998-05

5.  Clonal analysis of multiple point mutations in the N-ras gene in patients with acute myeloid leukemia.

Authors:  K Kubo; T Naoe; H Kiyoi; H Fukutani; Y Kato; T Oguri; S Yamamori; Y Akatsuka; Y Kodera; R Ohno
Journal:  Jpn J Cancer Res       Date:  1993-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.